U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
labetuzumab [INN]
Preferred Name English
LABETUZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
Labetuzumab [WHO-DD]
Common Name English
LABETUZUMAB [USAN]
Common Name English
MN14 MONOCLONAL ANTIBODY TO CARCINOEMBRYONIC ANTIGEN
Common Name English
HMN-14
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 113498
Created by admin on Mon Mar 31 22:47:28 GMT 2025 , Edited by admin on Mon Mar 31 22:47:28 GMT 2025
FDA ORPHAN DRUG 117998
Created by admin on Mon Mar 31 22:47:28 GMT 2025 , Edited by admin on Mon Mar 31 22:47:28 GMT 2025
NCI_THESAURUS C2456
Created by admin on Mon Mar 31 22:47:28 GMT 2025 , Edited by admin on Mon Mar 31 22:47:28 GMT 2025
Code System Code Type Description
ChEMBL
CHEMBL2108501
Created by admin on Mon Mar 31 22:47:28 GMT 2025 , Edited by admin on Mon Mar 31 22:47:28 GMT 2025
PRIMARY
DRUG BANK
DB05097
Created by admin on Mon Mar 31 22:47:28 GMT 2025 , Edited by admin on Mon Mar 31 22:47:28 GMT 2025
PRIMARY
USAN
KK-115
Created by admin on Mon Mar 31 22:47:28 GMT 2025 , Edited by admin on Mon Mar 31 22:47:28 GMT 2025
PRIMARY
NCI_THESAURUS
C2043
Created by admin on Mon Mar 31 22:47:28 GMT 2025 , Edited by admin on Mon Mar 31 22:47:28 GMT 2025
PRIMARY
INN
8127
Created by admin on Mon Mar 31 22:47:28 GMT 2025 , Edited by admin on Mon Mar 31 22:47:28 GMT 2025
PRIMARY
SMS_ID
100000181741
Created by admin on Mon Mar 31 22:47:28 GMT 2025 , Edited by admin on Mon Mar 31 22:47:28 GMT 2025
PRIMARY
CAS
219649-07-7
Created by admin on Mon Mar 31 22:47:28 GMT 2025 , Edited by admin on Mon Mar 31 22:47:28 GMT 2025
PRIMARY
WIKIPEDIA
Labetuzumab
Created by admin on Mon Mar 31 22:47:28 GMT 2025 , Edited by admin on Mon Mar 31 22:47:28 GMT 2025
PRIMARY
FDA UNII
EFE6X5M3UY
Created by admin on Mon Mar 31 22:47:28 GMT 2025 , Edited by admin on Mon Mar 31 22:47:28 GMT 2025
PRIMARY
ACTIVE MOIETY
LABETUZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966